Skip to main content

Peer Review reports

From: Prognostic factors and risk stratification in patients with castration-resistant prostate cancer receiving docetaxel-based chemotherapy

Original Submission
14 Jun 2015 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
16 Mar 2016 Editorially accepted
22 Mar 2016 Article published 10.1186/s12894-016-0133-y

You can find further information about peer review here.

Back to article page